Scott D. Grimes - Apr 1, 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Apr 1, 2022
Transactions value $
-$342,176
Form type
4
Date filed
4/5/2022, 04:55 PM
Previous filing
Mar 24, 2022
Next filing
Apr 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise $0 +14.9K +6.92% $0.00 231K Apr 1, 2022 Direct F1
transaction CDLX Common Stock Sale -$141K -2.5K -1.08% $56.40 228K Apr 4, 2022 Direct F2, F3
transaction CDLX Common Stock Sale -$178K -3.1K -1.36% $57.40 225K Apr 4, 2022 Direct F2, F4
transaction CDLX Common Stock Sale -$23.2K -400 -0.18% $58.09 225K Apr 4, 2022 Direct F2, F5
holding CDLX Common Stock 53.1K Apr 1, 2022 See Footnote F6
holding CDLX Common Stock 55.8K Apr 1, 2022 See Footnote F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -14.9K -33.33% $0.00 29.8K Apr 1, 2022 Common Stock 14.9K Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.93 to $57.90, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.05 to $58.17, inclusive.
F6 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
F7 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F8 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F9 The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.